1. A controlled trial of HNSCC patient‐derived xenografts reveals broad efficacy of PI3Kα inhibition in controlling tumor growth. Issue 8 (18th December 2018) Authors: Ruicci, Kara M.; Meens, Jalna; Sun, Ren X.; Rizzo, Giananthony; Pinto, Nicole; Yoo, John; Fung, Kevin; MacNeil, Danielle; Mymryk, Joe S.; Barrett, John W.; Boutros, Paul C.; Ailles, Laurie; Nichols, Anthony C. Journal: International journal of cancer Issue: Volume 145:Issue 8(2019) Page Start: 2100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗